JPWO2023018972A5 - - Google Patents

Info

Publication number
JPWO2023018972A5
JPWO2023018972A5 JP2024533929A JP2024533929A JPWO2023018972A5 JP WO2023018972 A5 JPWO2023018972 A5 JP WO2023018972A5 JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024533929 A JP2024533929 A JP 2024533929A JP WO2023018972 A5 JPWO2023018972 A5 JP WO2023018972A5
Authority
JP
Japan
Prior art keywords
liver
patient
fibrosis
elf
score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532957A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040227 external-priority patent/WO2023018972A1/en
Publication of JP2024532957A publication Critical patent/JP2024532957A/ja
Publication of JPWO2023018972A5 publication Critical patent/JPWO2023018972A5/ja
Pending legal-status Critical Current

Links

JP2024533929A 2021-08-13 2022-08-12 ウデナフィル組成物を用いた線維肝状態を処置する方法および組成物 Pending JP2024532957A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163233133P 2021-08-13 2021-08-13
US63/233,133 2021-08-13
PCT/US2022/040227 WO2023018972A1 (en) 2021-08-13 2022-08-12 Methods and compositions for treating fibrotic liver conditions, using udenafil compositions

Publications (2)

Publication Number Publication Date
JP2024532957A JP2024532957A (ja) 2024-09-10
JPWO2023018972A5 true JPWO2023018972A5 (enrdf_load_stackoverflow) 2025-08-19

Family

ID=83355014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533929A Pending JP2024532957A (ja) 2021-08-13 2022-08-12 ウデナフィル組成物を用いた線維肝状態を処置する方法および組成物

Country Status (7)

Country Link
US (2) US20230218622A1 (enrdf_load_stackoverflow)
EP (1) EP4384176A1 (enrdf_load_stackoverflow)
JP (1) JP2024532957A (enrdf_load_stackoverflow)
AU (1) AU2022325803A1 (enrdf_load_stackoverflow)
CA (1) CA3229274A1 (enrdf_load_stackoverflow)
MX (1) MX2024001972A (enrdf_load_stackoverflow)
WO (1) WO2023018972A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12396708B2 (en) * 2024-01-08 2025-08-26 Echosens Sa Method for determining an index for assessing a cardiac function of a subject
EP4582017A1 (en) * 2024-01-08 2025-07-09 Echosens Method for determining an index for assessing a cardiac function of a subject

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202254D0 (en) * 2002-01-31 2002-03-20 Pfizer Ltd Prevention of scarring
RU2369392C2 (ru) * 2005-06-10 2009-10-10 Донг-А Фармасьютикал. Ко., Лтд. Средство для профилактики и лечения заболеваний печени, содержащее производное пиразолопиримидинона
PE20170469A1 (es) 2014-08-12 2017-04-21 Mezzion Pharma Co Ltd Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontano que utilizan composiciones de udenafilo

Similar Documents

Publication Publication Date Title
Braunwald Effects of digitalis on the normal and the failing heart
US20150080464A1 (en) Melatonin agonist treatment
WO2008122190A1 (fr) Composition comprenant de la l-carnitine ou ses dérivés et son utilisation
TWI331920B (en) Unit dosage form for relieving or treating constipation in human patients
CN108619138B (zh) 血管紧张素受体拮抗剂和脑啡肽酶抑制剂的复合物及其用途
KR20110042344A (ko) 뇌졸중 또는 일과성 허혈 발작을 예방하기 위한 약제의 제조에서의 드로네다론의 용도
JPWO2020080499A1 (ja) 新規医薬組成物
JP7701757B2 (ja) タウロデオキシコール酸またはその薬学的に許容される塩を有効成分として含む新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療用組成物
US20160287535A1 (en) Uses and Methods for the Treatment of Liver Diseases or Conditions
JPWO2023018972A5 (enrdf_load_stackoverflow)
CN1112920C (zh) 氨基四氢化萘衍生物在制备治疗心脏病的药物中用途
WO2008057464A2 (en) Compositions and methods for improving the bioavailability of liothyronine
EP1732551A1 (en) Perhexilin for treating chronic heart failure
Zusman et al. Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension
CN107569476A (zh) 含有乙酰紫草素的药物组合物及其在肺动脉高压药物中的应用
JP7517993B2 (ja) 睡眠の質の改善剤
KR20180033310A (ko) 위장 장애 치료를 위한 프로스타글란딘 유도체
CN119630395A (zh) 用于治疗特发性肺纤维化的组合物和方法
WO2021214717A1 (en) Dosing regimen for the use of siponimod for the treatment of acute respiratory distress syndrome
JP5923044B2 (ja) 活性成分としてｌ−カルニチンまたはプロピオニルｌ−カルニチンを含む慢性静脈不全の予防または治療のための併用組成物
Kopecky et al. Enalaprilat-enhanced renography in a rat model of renovascular hypertension
CN112972440B (zh) 麝香酮在制备防治抑郁症的药物中的用途
JPH08253415A (ja) 抗動脈硬化治療剤
KR20020005772A (ko) 심장혈관질환의 치료를 위한 아미노테트랄린추출물
Klahr et al. The effects of indoramin in essential arterial hypertension: a placebo-controlled trial